Medicine News and Research

RSS

CardioNexus to launch Panasonic CardioHealth Station at American College of Cardiology 2011 Annual Scientific Sessions

CardioNexus Corporation an affiliated company of Panasonic Healthcare Co. Ltd., will introduce Panasonic CardioHealth® Station at the 2011 Annual Scientific Sessions of the American College of Cardiology.

From PHC Europe B.V. 31 Mar 2011

Boceprevir drug can help cure hard-to-treat hepatitis C

The drug boceprevir helps cure hard-to-treat hepatitis C, says Saint Louis University investigator Bruce R. Bacon, M.D., author of the March 31 New England Journal of Medicine article detailing the study's findings.

31 Mar 2011

20-year data shows bariatric surgery to reduce risk of heart attack and stroke in diabetics

In the longest study of its kind, bariatric surgery has been shown to reduce the risk of heart attack and stroke in patients with diabetes. These results and other groundbreaking research were presented at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes, hosted by NewYork-Presbyterian Hospital and Weill Cornell Medical College.

31 Mar 2011

Electrophysiologists use new robotic system to treat cardiac arrhythmias

Cardiac experts who fix arrhythmias, which are electrical problems of the heart, must perform complex catheter procedures while the heart is still beating in order to pinpoint where an electrical malfunction is taking place.

31 Mar 2011

3D experiments reveal MSCs have potential to produce different cell types

A type of adult stem cell is now proving itself more versatile for research and therapies thanks to revolutionary 3D experiments. These cells have already shown great promise for repairing damaged bone and cartilage but until now have been fairly limited in the types of cells they can form in the laboratory.

31 Mar 2011

Three-drug cocktail more effective against hepatitis C virus

A three-drug cocktail can eliminate the hepatitis C virus in patients far more effectively than the current two-drug regimen, according to researchers at Henry Ford Hospital.

31 Mar 2011

Regulus obtains exclusive rights from NYU for miR-33a, 33b to treat metabolic diseases

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative new medicines targeting microRNAs, today announced that it has obtained exclusive rights from New York University for intellectual property covering methods of use in modulating microRNA-33a and microRNA-33b for metabolic diseases such as atherosclerosis and metabolic syndrome.

31 Mar 2011

Study: Diet-exercise can improve physical performance in obese seniors

For obese seniors, dieting and exercise together are more effective at improving physical performance and reducing frailty than either alone.

31 Mar 2011

Tips on neurobiology of learning

Everyone would like MDs to have the best education - and to absorb what they are taught. The lead article in the April 4 issue of the journal Academic Medicine connects research on how the brain learns to how to incorporate this understanding into real world education, particularly the education of doctors.

31 Mar 2011

Study provides insight into kidney cancer

Researchers at UT Southwestern Medical Center have discovered genetic pathways to starve selectively kidney cancer cells.

31 Mar 2011

Low doses of estrogen, growth hormone can increase height in girls with Turner syndrome

Giving girls with Turner syndrome low doses of estrogen, as well as growth hormone, years before the onset of puberty, increases their height and offers a wealth of other benefits, say a team of researchers led by Thomas Jefferson University.

31 Mar 2011

Could HIV-infected organs save 'lives?

Johns Hopkins researchers argue for reversing ban on transplanting infected organs and making them available to HIV-infected patients

30 Mar 2011

Gilead and Yale enter multi-year cancer research collaboration

Gilead Sciences, Inc. and Yale School of Medicine today announced the formation of a multi-year research collaboration focused on the discovery of novel cancer therapies. The research effort will initially span four years with an option to renew for up to ten years.

30 Mar 2011

Traditional Chinese herbal medicine is an effective skin whitening cream

Scientists today reported discovery of the active ingredients in an herb used in traditional Chinese medicine for skin whitening, changing skin color to a lighter shade.

30 Mar 2011

GI Dynamics announces positive results from EndoBarrier studies against type 2 diabetes

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, announced today new results from three studies that demonstrate the positive effects of the EndoBarrier Gastrointestinal Liner on type 2 diabetes, weight loss and other metabolic factors.

30 Mar 2011

In Calif., nurses to take greater role in providing primary care

While the LA Times reports that nurses are poised to help meet the requirements of the health law, The Chicago Sun-Times reports that more young doctors are choosing primary care careers.

30 Mar 2011

TAP announces new corporate identity

The Automation Partnership, a leading supplier of innovative automation for life science applications today announced that the company will now be known as TAP Biosystems.

30 Mar 2011

Prostate cancer drug and a new drug to prevent preterm births cause cost concerns, controversy

News outlets report on the political dilemma involved with Provenge — a cancer drug — as well as the impact that Makena — the medicine that can prevent preterm births — could have on the nation's high health care costs.

30 Mar 2011

WHO Director-General responds to draft report on agency's handling of H1N1 pandemic

WHO Director-General Margaret Chan on Monday responded to the first results of a probe into the agency's response to the H1N1 pandemic, Agence France-Presse reports.

30 Mar 2011

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

Silence Therapeutics plc a leading global RNA interference therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology Annual Meeting.

30 Mar 2011

Medicine News and Research

CardioNexus to launch Panasonic CardioHealth Station at American College of Cardiology 2011 Annual Scientific Sessions

Boceprevir drug can help cure hard-to-treat hepatitis C

20-year data shows bariatric surgery to reduce risk of heart attack and stroke in diabetics

Electrophysiologists use new robotic system to treat cardiac arrhythmias

3D experiments reveal MSCs have potential to produce different cell types

Three-drug cocktail more effective against hepatitis C virus

Regulus obtains exclusive rights from NYU for miR-33a, 33b to treat metabolic diseases

Study: Diet-exercise can improve physical performance in obese seniors

Tips on neurobiology of learning

Study provides insight into kidney cancer

Low doses of estrogen, growth hormone can increase height in girls with Turner syndrome

Could HIV-infected organs save 'lives?

Gilead and Yale enter multi-year cancer research collaboration

Traditional Chinese herbal medicine is an effective skin whitening cream

GI Dynamics announces positive results from EndoBarrier studies against type 2 diabetes

In Calif., nurses to take greater role in providing primary care

TAP announces new corporate identity

Prostate cancer drug and a new drug to prevent preterm births cause cost concerns, controversy

WHO Director-General responds to draft report on agency's handling of H1N1 pandemic

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News